Home
Hannah Valantine, Director: BridgeBio Pharma BBIO Buy · Filed 25/06/30
Trade details
- Type
- Insider buy
- Amount
- $24,948.48
- Shares · price
- 1,752 sh · $14.24 a share
- Held after
- 3,294 sh
- Person
- Hannah ValantineDirector
- Trade date
- 21/12/29
- Filed
- 25/06/30
- Days to filing
- 1,279 days
Holdings up 113.6%
- Insiders buying this week
- 1 insiders
- Holding change
- +113.6%
BridgeBio Pharma trades, last 26 weeks
What else happened in BridgeBio Pharma around then
Filed or reported within 30 days of the trade day · 21/11/29~22/01/28Hannah Valantine's recent trades
- Hannah Valantine
Planned sale10b5-1 planCareDx
Planned sale10b5-1 planCareDx
CDNA
$856.2K
28,779 sh
$856.2K
Filed 07/16
Traded 07/16
- Hannah Valantine
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 planBridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/24
Traded 06/22
- Hannah Valantine
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 planBridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/24
Traded 06/23
- Hannah Valantine
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 planBridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/23
Traded 06/23
- Hannah Valantine
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 planBridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/22
Traded 06/22
